REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2023

Type / Class
Equity / SPONSORED ADS
Symbol
RDHL on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$2,175 0
2023 Q1 300 $2,175 -$1,501,568 $7.25 1
2022 Q4 10,717,925 $1,502,475 +$882,077 $0.14 36
2022 Q3 2,884,553 $1,453,214 -$1,647,605 $0.50 35
2022 Q2 4,167,075 $3,885,746 -$696,664 $0.87 43
2022 Q1 4,724,797 $11,905,892 -$346,454 $2.52 44
2021 Q4 4,850,941 $12,511,952 -$2,326,614 $2.58 53
2021 Q3 5,305,707 $24,292,763 -$10,822,955 $4.58 56
2021 Q2 7,134,489 $49,094,475 -$25,443,491 $6.88 52
2021 Q1 10,584,710 $77,377,853 +$18,691,800 $7.32 59
2020 Q4 8,027,918 $64,978,460 +$2,852,927 $8.08 57
2020 Q3 7,585,734 $77,461,000 +$6,615,115 $10.22 52
2020 Q2 6,954,237 $46,579,685 +$5,475,091 $6.69 44
2020 Q1 6,125,325 $27,723,684 -$3,102,817 $4.53 46
2019 Q4 6,490,900 $39,394,795 -$9,702,915 $6.07 44
2019 Q3 8,065,835 $56,792,890 -$1,065,339 $7.04 38
2019 Q2 8,279,384 $53,807,633 +$2,350,102 $6.50 34
2019 Q1 7,796,144 $64,788,706 -$3,649,566 $8.31 36
2018 Q4 8,270,797 $45,904,059 +$7,725,356 $5.55 36
2018 Q3 6,690,917 $59,050,257 +$17,017,495 $8.83 39
2018 Q2 4,761,845 $40,598,048 +$5,791,820 $8.53 29
2018 Q1 4,136,766 $21,297,060 +$3,472,367 $5.15 29
2017 Q4 3,462,714 $17,796,133 +$4,670,637 $5.14 32
2017 Q3 1,801,490 $19,471,540 -$645,671 $10.81 24
2017 Q2 1,873,551 $16,153,810 -$2,099,965 $8.62 26
2017 Q1 2,100,005 $20,140,576 -$2,990,763 $9.59 27
2016 Q4 2,378,926 $24,883,000 +$4,215,358 $10.46 24
2016 Q3 1,963,009 $27,271,000 +$271,457 $13.90 24
2016 Q2 1,948,468 $21,184,000 -$6,586,006 $10.87 23
2016 Q1 2,490,574 $30,505,000 -$965,621 $12.25 23
2015 Q4 2,567,398 $33,063,000 -$4,042,623 $12.88 22
2015 Q3 2,856,580 $36,878,000 +$21,284,734 $12.91 24
2015 Q2 1,204,566 $21,213,000 -$3,265,797 $17.61 19
2015 Q1 1,414,320 $20,576,000 +$6,504,572 $14.55 14
2014 Q4 967,145 $12,887,000 -$149,755 $13.33 10
2014 Q3 906,713 $11,942,000 -$8,130 $13.17 7
2014 Q2 907,287 $15,867,000 -$2,787,595 $17.48 7
2014 Q1 2,642,815 $15,502,000 +$15,093,000 $13.92 8